FR3693M - Hydroxy-cinnamic acid derivatives as drugs that inhibit l. dopa and 5 hydroxytryptophan decarboxylases. - Google Patents

Hydroxy-cinnamic acid derivatives as drugs that inhibit l. dopa and 5 hydroxytryptophan decarboxylases.

Info

Publication number
FR3693M
FR3693M FR941566A FR941566A FR3693M FR 3693 M FR3693 M FR 3693M FR 941566 A FR941566 A FR 941566A FR 941566 A FR941566 A FR 941566A FR 3693 M FR3693 M FR 3693M
Authority
FR
France
Prior art keywords
decarboxylases
hydroxytryptophan
dopa
drugs
inhibit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR941566A
Other languages
French (fr)
Inventor
J Cahn
J C Denis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PATRICE COIRRE
Original Assignee
PATRICE COIRRE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PATRICE COIRRE filed Critical PATRICE COIRRE
Priority to FR941566A priority Critical patent/FR3693M/en
Priority to CH817264A priority patent/CH438271A/en
Priority to BE649681A priority patent/BE649681A/xx
Priority to NL646408050A priority patent/NL150681B/en
Application granted granted Critical
Publication of FR3693M publication Critical patent/FR3693M/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR941566A 1963-07-16 1963-07-16 Hydroxy-cinnamic acid derivatives as drugs that inhibit l. dopa and 5 hydroxytryptophan decarboxylases. Expired FR3693M (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR941566A FR3693M (en) 1963-07-16 1963-07-16 Hydroxy-cinnamic acid derivatives as drugs that inhibit l. dopa and 5 hydroxytryptophan decarboxylases.
CH817264A CH438271A (en) 1963-07-16 1964-06-23 Process for the preparation of hydroxycinnamic acid derivatives
BE649681A BE649681A (en) 1963-07-16 1964-06-24
NL646408050A NL150681B (en) 1963-07-16 1964-07-15 PROCESS FOR THE PREPARATION OF A DIURETIC ACTIVE PHARMACEUTICAL PREPARATION IN which 3,4-DIHYDROXYCINNIC ACID IS INCLUDED AND FORMED PHARMACEUTICAL PREPARATION OBTAINED BY THIS PROCESS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR941566A FR3693M (en) 1963-07-16 1963-07-16 Hydroxy-cinnamic acid derivatives as drugs that inhibit l. dopa and 5 hydroxytryptophan decarboxylases.

Publications (1)

Publication Number Publication Date
FR3693M true FR3693M (en) 1965-11-22

Family

ID=8808388

Family Applications (1)

Application Number Title Priority Date Filing Date
FR941566A Expired FR3693M (en) 1963-07-16 1963-07-16 Hydroxy-cinnamic acid derivatives as drugs that inhibit l. dopa and 5 hydroxytryptophan decarboxylases.

Country Status (4)

Country Link
BE (1) BE649681A (en)
CH (1) CH438271A (en)
FR (1) FR3693M (en)
NL (1) NL150681B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031326A1 (en) * 2003-06-27 2004-12-28 Univ Degli Studi Milano SALTS OF HYDROXYCINNAMIC ACIDS AND OPTICALLY ACTIVE HYDROXYSTYLBENES.

Also Published As

Publication number Publication date
NL6408050A (en) 1965-01-18
CH438271A (en) 1967-06-30
NL150681B (en) 1976-09-15
BE649681A (en) 1964-10-16

Similar Documents

Publication Publication Date Title
FR3447M (en) Derivatives of lipoic acid.
BE766879A (en) N-FLUORODICHLOROMETHYLTHIOSULFAMIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MICROBICIDAL AND FUNGICIDAL AGENTS
BE775607A (en) HIGH STABILITY AQUEOUS ALCOHYLHYDROGENOPOLYSILOXANE EMULSIONS
FR3693M (en) Hydroxy-cinnamic acid derivatives as drugs that inhibit l. dopa and 5 hydroxytryptophan decarboxylases.
FR3529M (en) New derivative of anthranilic acid which can be used in therapy, in particular as an anti-inflammatory agent.
FR3784M (en) Derivatives of phenylacetic acid.
FR3513M (en) New derivatives of n-substituted alpha-amino acid esters.
FR3397M (en) Amides of isoindolinyl-2-acetic acid.
BE749650A (en) HERBICIDES CONTAINING HALOGENOACRYLIC ACID DERIVATIVES
FR1610M (en) New drugs consisting of (p-acyloxy-phenoxy) -benzoic acid derivatives.
BE752043A (en) BICYCLO- (2.2.2) -OCTANE-1-ACETIC ACID DERIVATIVES
FR1251M (en) Medicinal product based on n- (2,3-dichlorophenyl) anthranilic acid to fight inflammatory conditions.
FR2584M (en) New drugs consisting of derivatives of maleamic acid.
FR1535465A (en) New acylheterocyclic urea derivatives that can be used as agricultural antiparasitics
FR3625M (en) Medicinal product consisting of derivatives of theophylline-acetic acid.
FR1411116A (en) Isocyanuric acid derivatives, their preparation and applications
FR3591M (en) New isoquinoline derivatives and their preparation processes.
FR2819M (en) New rapidly soluble derivative of acethylsalicylic acid.
BE634852A (en) Isoindolinyl-2-acetic acid derivatives, their preparation and use.
FR1993M (en) Analgesic and hypnosedative drugs derived from trimethyl acetic acid.
FR1472975A (en) Organomercuric derivatives of isocyanuric acid
FR3305M (en) Trinicotinoylglycerin and its acid addition salts, useful as vasodilating agents.
FR1348617A (en) Solid compositions containing 2-pyrrolidone-5-carboxylic acid, its derivatives and their salts as humectants
FR1459769A (en) Sulfamic acid derivatives
FR1460109A (en) 2,4-hexadienehydroxamic acid and its derivatives